Objective-To confirm the effect of the endothelial protein receptor gene (PROCR) haplotypes H1 and H3 on venous thromboembolism (VTE), to study their effect on endothelial protein C receptor (EPCR) expression in human umbilical vein endothelial cells, and to investigate the functionality of H1 tagging single-nucleotide polymorphisms in an in vitro model. Approach and Results-Protein C (PC), activated PC, and soluble EPCR (sEPCR) levels were measured in 702 patients with VTE and 518 healthy individuals. All subjects were genotyped for PROCR H1 and H3. Human umbilical vein endothelial cells isolated from 111 umbilical cords were used to study the relation between PROCR haplotypes, PROCR mRNA, cellular distribution of EPCR, and rate of PC activation. Finally, the functionality of the intragenic PROCR H1 singlenucleotide polymorphisms was analyzed using a luciferase-based method. We confirmed that individuals carrying H1 have reduced VTE risk, increased plasma activated PC levels, and reduced plasma sEPCR levels and that individuals with the H3H3 genotype have an increased VTE risk and increased plasma sEPCR levels. In cultured human umbilical vein endothelial cells, H1 is associated with increased membrane-bound EPCR, increased rate of PC activation, and reduced sEPCR in conditioned medium, but does not significantly influence PROCR mRNA levels. In contrast, H3 is associated with reduced membrane-bound EPCR and increased sEPCR in human umbilical vein endothelial cell-conditioned medium, higher levels of a truncated mRNA isoform, and a lower rate of PC activation. Finally, we identified the g.2132T>C singlenucleotide polymorphism in intron 1 as an intragenic H1-specific functional single-nucleotide polymorphism. Conclusions-These results support a protective role of PROCR H1 against VTE and an increased risk of VTE associated with the H3 haplotype. (Arterioscler Thromb Vasc Biol. 2014;34:684-690.) 
T he endothelial protein C receptor (EPCR) is a key component of the protein C (PC) anticoagulant pathway. It is mainly expressed on the surface of endothelial cells, and it increases the rate of PC activation by the thrombin-thrombomodulin complex up to 20-fold. 1 EPCR also modulates the cytoprotective properties of activated PC (APC) in various inflammatory disorders. 2, 3 The EPCR gene (PROCR) spans 6 kb and consists of 4 exons. 4 The mature protein comprises 221 amino acids, including an N-terminal extracellular domain, a 25-aa transmembrane domain, and a 3-aa intracytoplasmic sequence. In vivo experiments have demonstrated the importance of EPCR in normal embryonic development; in PROCR knockout mice, fibrin deposition around trophoblast giant cells results in thrombosis at the maternal-embryonic interface. 5 Therefore, we hypothesized that DNA variations in PROCR that influence protein expression (levels) and function may be relevant. A soluble form of EPCR (sEPCR), which lacks the transmembrane domain and cytoplasmic tail, is present in human plasma, 6 possibly generated through proteolytic cleavage by metalloproteinase activity. 7 Four common haplotypes of PROCR have been reported, 8-10 3 of which contain ≥1 single-nucleotide polymorphisms (SNPs) that are haplotype specific (H1, H3, and H4). H2 contains the common allele of all SNPs (Figure 1 ). H1, which is tagged by the minor allele of g.4678G>C (rs9574), has been associated with increased plasma APC levels 8, [11] [12] [13] and in some, but not all, studies with a reduced risk of venous thromboembolism (VTE). [8] [9] [10] 12, 14, 15 A possible explanation for a protective effect of PROCR H1 against VTE would be the association with increased plasma APC levels. In fact, it has been reported that a low plasma level of APC, that is, in the absence of overt coagulation, is a strong risk factor for VTE. 16, 17 Presently, it is not known which SNP in PROCR H1 is responsible for the reported protective effect. H1 contains ≥10 intragenic haplotype-specific SNPs, and any of these might be responsible for the observed effects.
H3 is tagged by the minor allele of g.4600A>G (Ser219Gly; rs867186) and has been associated with the risk of venous [8] [9] [10] [11] [12] [13] [14] [15] 18, 19 and arterial thrombosis, [19] [20] [21] [22] [23] but with contradictory results. The presence of H3 results in increased plasma sEPCR levels, [8] [9] [10] [11] [12] [13] 18, 20, 22, 24 which is largely explained by a Ser219Gly substitution, which renders EPCR more susceptible to cleavage by metalloproteinases such as tumor necrosis factor-α converting enzyme/ADAM17. 7 Another mechanism that could link H3 to high plasma levels of sEPCR is its association with a truncated form of PROCR mRNA lacking the transmembrane and intracellular domains. 25 Recently, PROCR H3 has also been found to be associated with increased plasma levels of PC. 20, 26 Therefore, we aimed to verify the effects of H1 and H3 on VTE risk in a case-control study to investigate their effects on EPCR expression in human umbilical vein endothelial cells (HUVECs) and to identify the functional SNP that mediates the protection of H1 against VTE using luciferase constructs.
In the present study, we confirm previous reports on a protective effect of PROCR H1 against VTE 8, [11] [12] [13] [14] [15] and show, for the first time, that it is probably mediated by the observed increase in functional membrane-bound EPCR in HUVEC carrying the H1 haplotype and the resulting enhanced rate of PC activation. As reported earlier, the H3H3 genotype was associated with increased sEPCR and increased VTE risk, 9 and we demonstrate, for the first time, that it is also associated with reduced functional membrane-bound EPCR levels. Using a modified luciferase reporter system, we could identify the g.2532T>C (rs2069948) SNP in intron 1 as a functional H1-specific SNP, although there are probably more.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Clinical Characteristics of the Subjects
The clinical characteristics of the study subjects are presented in Table 1 . About 34% of the patients had spontaneous thrombosis, which is defined as thrombosis in the absence of known triggering factors (use of oral contraceptives, pregnancy, surgery, trauma, or immobilization). The prevalence of classical prothrombotic polymorphisms was similar to that described in other series.
PROCR Haplotypes and VTE Risk
The 702 patients and 518 control subjects were successfully genotyped for PROCR haplotypes H1 and H3. Table 2 shows the genotype distributions in patients and controls. To analyze the associations between genotypes and VTE, we performed logistic regression analyses. In univariate analysis, we confirmed that the presence of the H1H1 genotype significantly reduces the risk of VTE. 8, [11] [12] [13] [14] [15] Adjustment for sex, age, and the presence of thrombophilic defects in a multivariate analysis did not significantly modify the odds ratio. We also confirmed that the presence of the H3H3 genotype is associated with an increased risk of VTE. 9
APC, sEPCR, and PC Levels
Because variations in the PROCR gene contribute to circulating plasma PC, 20,26 APC, 8, [11] [12] [13] and sEPCR [8] [9] [10] [11] [12] [13] 18, 20, 22, 24 levels, we measured these levels in 462 patients with VTE (excluding those undergoing coumarin therapy) and 510 healthy individuals. As previously reported, 17 the levels of circulating APC were lower in patients with VTE (1.03±0.37 ng/mL) than in controls (1.25±0.40 ng/mL; P<0.001; Table 3 ). Both in patients and controls, APC levels increased with the number of H1 alleles (P<0.001), whereas they tended to decrease with increasing number of H3 alleles ( Table 3 ).
Plasma sEPCR levels were similar in patients and controls (Table 3 ). When sEPCR levels were distributed according to genotypes, sEPCR levels strongly increased when the number of H3 alleles increased (P<0.001), confirming previous results. [8] [9] [10] [11] [12] [13] 18, 20, 22, 24 There was no obvious effect of the H1 allele.
In agreement with previous reports, 20, 26 both in patients and controls, antigen PC levels were significantly higher in carriers of the PROCR H3 allele than in noncarriers. Thus, PC levels were 101±17%, 103±19%, and 102±16% in controls carrying the HxHx, HxH1, and H1H1 genotypes, respectively, and 114±19% and 116±24% in controls carrying the HxH3 and H1H3 genotypes, respectively (P<0.001). In patients with VTE, PC levels were 100±21%, 103±20%, and 106±26% in carriers of the HxHx, HxH1, and H1H1 genotypes, respectively, and 122±17%, 110±18%, and 138±9% in carriers of the HxH3, H1H3, and H3H3 genotypes, respectively (P<0.001). These data indicate that the increased circulating APC levels observed in H1 carriers cannot be explained by an increase in PC levels in these individuals.
EPCR Protein and mRNA Levels in HUVECs
To further investigate whether the PROCR haplotypes H1 and H3 are functional and to identify the underlying mechanism, we used passage 2 HUVECs derived from 111 human umbilical cords from white newborns. Thirty-four HUVEC cultures were HxHx, 36 were HxH1, 27 H1H1, 5 H1H3, 8 HxH3, and 1 was H3H3. Figure 2 shows the concentration of EPCR in cell lysates and in conditioned medium (CM). EPCR levels in cell lysates increased (P<0.001), and sEPCR levels in the HUVEC-CM slightly decreased (P=0.024) with the number of H1 alleles. The total amount of EPCR measured in cell lysates and HUVEC-CM combined also increased with the number of H1 alleles ( Figure 2C ). In contrast, the presence of the H3 allele was associated with reduced levels of EPCR in cell lysates and, as expected, with increased levels in CM. This clearly establishes that the H3 allele leads not only to increased levels of sEPCR, but also to significantly reduced levels of EPCR on the cell membrane. We also measured the PROCR full-length and truncated mRNA levels in 90 HUVEC samples for which mRNA isolated from passage 1 confluent cultures was available. Figure 3 shows the results obtained. There was a nonsignificant decrease in PROCR full-length mRNA levels with increasing number of H1 alleles. Similarly, there was a trend to lower PROCR full-length mRNA levels when the number of H3 alleles increased, although these differences were again not significant ( Figure 3A ). As previously reported, 25 ,27 a truncated mRNA form was detected in HUVECs, representing from 0.3% to 0.5% of the total PROCR mRNA in HUVECs not carrying H3 and from 1% to 2.3% in HUVECs carrying H3 ( Figure 3B ). This small amount of the truncated isoform does not explain the large increase in sEPCR levels observed in H3 carriers.
PC Activation on HUVECs
PC activation on HUVECs carrying different combinations of haplotypes was compared ( Figure 4 ) to test the functionality of the membrane-bound EPCR. Because the thrombomodulin gene (THBD) g.1418C>T polymorphism has been associated with the rate of PC activation in cultured HUVECs, 28 we selected passage 2 HUVECs which were homozygous wild type for the THBD g.1418C>T SNP (1418CC). The rate of PC activation increased with the number of H1 alleles, whereas it decreased in the presence of H3. Preincubation of HUVECs with monoclonal antibody RCR-379 to block EPCR-dependent PC activation drastically reduced PC activation (Figure 4 ). In the same experiment, part of the HUVECs was used to measure the amount of EPCR in the cytosolic and cell membrane fractions. As seen in the top of Figure 4 , HUVECs carrying the H1 haplotype have more membrane-bound EPCR than HUVECs not carrying the H1 haplotype, and HUVECs carrying the H3 haplotype have less membrane-bound EPCR than noncarriers. Cytosolic fractions did not contain detectable EPCR (<0.3 ng/mL).
PROCR H1 In Vitro Functional Studies
The H1 haplotype covers a much larger region (>250 kb) than the 6-kb PROCR gene itself; however, to date, no functional elements have been ascertained outside the region characterized by the SNPs (Figure 1) . Therefore, to identify the H1 functional SNP(s), we focused initially on those SNPs encoded within PROCR itself. To study the functionality of the H1-specific SNPs in intron 1, intron 2, and the 3′ untranslated region (see Figure 1 ), we generated 3 sets of luciferase constructs in which we cloned PROCR intron 1, intron 2, or the 3′ untranslated region and downstream flanking region from H1 and H2, using the latter as the reference. After transfecting the human endothelial cell line EC-RF24 by electroporation, luciferase activity was measured. Constructs containing Figure 1 . PROCR haplotypes and single-nucleotide polymorphisms (SNPs). Numbering is according to Simmonds and Lane. 4 Circled letters correspond to specific alleles for each haplotype. Italicized numbers indicate extrapolated numbering for these SNPs because the sequence described by Simmonds and Lane 4 does not reach these positions. The H1 haplotype contains 10 specific alleles, the 1451T (rs2069943), 1541A (rs2069944), 1880C (rs2069945), 2532C (rs2069948), 2897A (rs945960), 3424C (rs871480), 3997C (rs2069952), 4678C (rs9574), 5632G (rs1415773), and 5663A (rs1415774). PROCR H1 intron 1 showed a significant reduction of 45% in luciferase activity compared with constructs containing H2 intron 1 (P=0.029). Constructs containing H1 intron 2 showed a 27% reduction in luciferase activity (P=0.071), and constructs containing the H1 3′ untranslated region and downstream flanking region showed a 14% increase in luciferase activity (P=0.383) compared with that of H2 ( Figure 5 ). These results indicate that PROCR intron 1 might contain a functional SNP, and therefore, we generated, by sitedirected mutagenesis, 4 sets of constructs in which we cloned each H1 SNP individually in the H2 background and again performed transfection experiments in EC-RF24 cells. As shown in Figure 6 , only the construct containing the 2532C allele (rs2069948) showed a significant 34.4% reduction in luciferase activity compared with the construct containing H2 (P=0.003), a reduction that is similar to that obtained when all 4 H1-specific SNPs are included compared with H2 (36.7%; P=0.006). Therefore, the g.2532T>C SNP seems to be the functional SNP responsible for the PROCR H1 effect observed in this in vitro model.
Discussion
In the present study, we confirmed that carriers of the H1H1 genotype in the PROCR gene have normal plasma sEPCR levels, higher levels of circulating APC, and a lower risk of VTE than those carrying other genotypes. We have shown for the first time that HUVECs carrying the H1 allele have significantly higher levels of membrane-bound EPCR and slightly lower sEPCR levels in HUVEC-CM than noncarriers. In agreement with this finding is the observation that the EPCR-dependent thrombin-mediated PC activation on intact HUVECs, as calculated from the experiments adding anti-EPCR (Figure 4) , was higher in H1 carrying cells than in non-H1 carrying cells. Together, these findings indicate that the reduced risk of VTE of H1H1 carriers is associated with an increased concentration of functional EPCR on the endothelial cells. The latter might be responsible for the association of the H1 allele with increased plasma APC concentrations. In contrast, the PROCR full-length mRNA levels were similar in HUVECs from H1 carriers and non-H1 carriers, which suggests that the increase in functional membrane-bound EPCR associated with H1 is not caused by an increase in gene expression.
Several studies have investigated the association between PROCR haplotypes and venous and arterial thrombosis, with conflicting results. Some studies showed a reduced risk of VTE in carriers of the H1H1 genotype, 8, 14, 15 whereas others did not find such an effect. 9, 10 An explanation for at least part of these discrepancies may lie in differences in study design and patient populations. Our present study is the largest casecontrol study performed with this aim.
We observed that the H3H3 genotype was associated with increased sEPCR levels and an increased risk of VTE, with . Luciferase activity of constructs containing PROCR intron 1, intron 2, or 3′ untranslated region (UTR) and downstream flanking region. Luciferase activity was measured 48 hours after transfection of EC-RF24 cells with constructs containing the PROCR H1 intron 1 or the H2 intron 1, constructs containing the H1 intron 2 or the H2 intron 2, and constructs containing the H1 or H2 3′ UTR and downstream flanking region. Data are expressed as mean±SEM of 3 to 5 experiments, in which ≥2 DNA preparations of each construct (wild type [wt] and mutant) were transfected in triplicate. Finally, the expression level of the mutant construct was calculated relative to the wt construct (H2), which was set at 100%. Figure 6 . Luciferase activity of constructs containing each single-nucleotide polymorphism of PROCR intron 1 H1 mutated individually. Luciferase activity was measured 48 hours after transfection of EC-RF24 cells with constructs containing the PROCR H2 intron 1, the H1 intron 1, and the intron 1 with the 1451T allele (rs2069943), the 1541A allele (rs2069944), the 1880C allele (triallelic; rs2069945), and the 2532C allele (rs2069948). Data are expressed as mean±SEM of 3 to 5 experiments, in which ≥2 DNA preparations of each construct (wild type [wt] and mutant) were transfected in triplicate. Finally, the expression level of the mutant construct was calculated relative to the wt construct (H2), which was set at 100%.
higher sEPCR levels in HUVEC-CM and, for the first time, with reduced functional membrane-bound EPCR levels. This reduction in functional membrane-bound EPCR seems not to be attributable to reduced gene transcription because the levels of PROCR full-length mRNA did not vary in the presence of H3. As expected, the levels of PROCR truncated mRNA significantly increased with the number of H3 alleles. It is however unlikely that this is the cause of the large increase in sEPCR levels observed in H3 carriers. 25 The increased risk of VTE associated with the H3H3 genotype is in agreement with previous reports. 9, 12, 19 However, its mechanism is not fully understood. Our data suggest that it could be mediated by the increased EPCR shedding from the endothelial membrane, leading to significantly lower EPCR levels on the cell membrane and to a large increase in sEPCR levels. This effect of the H3 haplotype might be explained by the Ser219Gly substitution (rs867186), which would render EPCR more susceptible to cleavage by metalloproteinases such as ADAM17. 24 Qu et al 24 also showed that HUVECs carrying the H3 haplotype produced more sEPCR in CM than those carrying the H1 haplotype and that this resulted in reduced EPCR on the endothelial membranes. Unfortunately, they did not completely separate H1 from H3 in their calculations, making it difficult to compare their results with our present data.
We know that the H1 haplotype covers a much larger region (>250 kb) than the PROCR gene itself and that the functional variation(s) responsible for the observed associations might be located anywhere in this haplotype. To date, functional elements have not been described in the long region upstream of the PROCR gene that is also part of H1. Therefore, to identify SNPs responsible for the protective effect of H1, we restricted our in vitro analysis to the 10 H1-specific SNPs encoded within the PROCR gene. Using a modified luciferase reporter system, we identified the g.2532T>C SNP (rs2069948) in intron 1 as a plausible functional SNP in this part of the H1 haplotype. In our reporter system, this SNP is associated with reduced protein expression most likely by influencing splicing efficiency. The g.2532T>C SNP is located 16 bases from the intron 1-exon 2 splicing site in the branch point consensus sequence YTNAY, with 2532T/C at the position of the first pyrimidine (C or T) residue and the consensus A being used for the branch site. The 2532C allele is phylogenetically well conserved and is the ancestral allele, which suggests that this SNP might be functional. Interestingly, the g.2532T>C SNP reduced protein expression in our in vitro model system, which is opposite of what might be expected based on the observed association between H1 and EPCR expression in HUVECs and on the predictions of an in silico analysis using the Human Splicing Finder 29 (data not shown). On the contrary, it might be in agreement with the trend of reduced PROCR mRNA expression with increasing number of H1 alleles. Definite answers await further functional analysis of the H1-specific SNPs outside the PROCR gene itself.
In the present study, we have contributed to the further elucidation of the mechanism by which PROCR haplotypes 1 and 3 influence the risk of VTE. Our results show that the protective effect of H1 is associated with increased levels of functional membrane-bound EPCR, which will lead to an enhanced rate of PC activation. In contrast, the increased risk of VTE associated with H3 may be explained by the decrease in functional membrane-bound EPCR observed in HUVECs carrying the H3 haplotype.
